Company profile
SEC EDGAR ↗- Industry
- Pharmaceutical Preparations
- Listed
- NYSE: JNJ
- Incorporated
- NJ
- Headquarters
- New Brunswick, NJ
- Fiscal year end
- Jan 3
Financials
FY2025- Revenue
- $94.2B
- Net income
- $26.8B
- Total assets
- $199.2B
| Fiscal year | Revenue | Net income | Total assets |
|---|---|---|---|
| FY2025 | $94.2B | $26.8B | $199.2B |
| FY2024 | $88.8B | $14.1B | $180.1B |
| FY2023 | $85.2B | $35.2B | $167.6B |
| FY2023 | $80.0B | $17.9B | $187.4B |
| FY2022 | $78.7B | $20.9B | $182.0B |
| FY2021 | $82.6B | $14.7B | $174.9B |
Reported fiscal years from SEC filings (10-K) — SEC EDGAR ↗. Stratrix is a strategy publication, not a real-time financial data service.
In depth
Decisions on record
2 verified Decision Cases on Johnson & Johnson, and the casebook each one belongs to.
| Fork date | Decision type | What Johnson & Johnson chose | Where it stood | The story | Casebook |
|---|---|---|---|---|---|
| 2021 | Adjacency Expansion | Spin off Consumer Health | J&J announced intention to split off at least 80.1% of Kenvue shares through a tax-free exchange offer (2023-07) | Read the story → | Adjacency Expansion Casebook → |
| 2022 | The Fork | Cash plus contingent value right | Tender offer expired December 21, 2022 with about 57.1% of shares tendered; acquisition completed December 22, 2022 without a stockholder vote (2022-12) | Read the story → | The Fork Casebook → |
The decisions Johnson & Johnson faced, as kits you can run.
Each pack takes one of these decisions and gives you the framework, a deck for the room, a model that resolves to one number, and the sourced cases behind it. $499, one-time.
The analyses
Tools to try
- Ansoff move finderFramework: Ansoff Matrix
- Business model canvas builderFramework: Business Model Canvas
- Change readiness checkFramework: Kotter's 8-Step Change Model
- Five Forces scorerFramework: Porter's Five Forces
- SMART goal builderFramework: SMART Goals
- SWOT builderFramework: SWOT Analysis
More from Stratrix
The Business Model Wizard
Make the seven choices that define your model, test your numbers against real companies, and meet the rival AI would build against you.
Free · about twelve minutesBuild your Model Thesis →Test a decision, free
Set a live decision against the companies that made it before you.
AcquisitionsThe Distance TestDivestituresThe Divestiture TestDiversificationThe Diversification TestMake or buyThe Make-or-Buy TestStratrix Team
Every Casebook, three Strategy Packs a seat each year and Ask Stratrix, for teams that face these decisions all year.
$1,999 a year · $499 a seatWhat is included →New analyses, by email
The defining moves in business, and what they teach, as they publish.